Sourabh Vellala

Sourabh Vellala

Auto-generated profile, based on publicly available information

Sourabh Vellala

Department of Orthopaedics, University of Maryland Medical Center, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2025 in Journal of Orthopaedics
Verified
Journal Article
Open access
SVSourabh Vellala
Sourabh Vellala
KHKathleen Healey
Kathleen Healey
MMMichael A. McCurdy
Michael A. McCurdy
DVDominic J. Ventimiglia
Dominic J. Ventimiglia
JBJoseph M. Blommer
Joseph M. Blommer
SMSean J. Meredith
Sean J. Meredith
Orthopaedic surgery patients have among the highest rates of preoperative opioid use. Prior literature links preoperative opioid use with worse patient-reported outcomes (PROs) in other orthopedic procedures, but studies examining this relationship 2 years after hip arthroscopy are limited. This study aimed to investigate the impact of preoperative opioid use on 2-year PROs after hip arthroscopy. We hypothesized that preoperative opioid use would be associated with worse pain, function, and mental health at 2-year follow-up. Patients undergoing hip arthroscopy from October 2015 to February 2022 were retrospectively identified. Patients completed surveys containing multiple PROs, including six Patient-Reported Outcomes Measurement Information System (PROMIS) domains at baseline and 2 years postoperatively. A statewide Prescription Drug Monitoring Program (PDMP) identified opioid prescriptions filled within 3 months preoperatively, standardized as morphine milligram equivalents (MMEs). Of 117 eligible patients, 84 (71.8 %) completed 2-year surveys, and 11 (13 %) filled an opioid prescription within 3 months of surgery. At baseline, preoperative opioid use was associated with worse PROMIS Fatigue (p < .001), Numeric Pain Scale (NPS) operative hip (p = .043), Tegner Activity Scale (TAS) (p = .039), and Marx Activity Rating Scale lower extremity (MARS LE) (p = .036). At 2 years, preoperative opioid use was associated with worse PROMIS Fatigue (54.3 vs 45.7, p = .007), TAS (2.9 vs 4.9, p = .025), and MARS LE (21.1 vs 41.8, p = .047). On regression, preoperative MMEs predicted worse 2-year Musculoskeletal Outcomes Data Evaluation and Management System (MODEMS) met expectations (Est. = -0.001, p = .005) and less improvement in 2-year NPS operative hip (Est. = 8.78e-5, p = .032). Preoperative opioid use was associated with worse 2-year PROMIS Fatigue, TAS, and MARS LE. Preoperative MMEs independently predicted worse MODEMS met expectations and less improvement in NPS operative hip at 2 years. These findings suggest preoperative opioid use negatively affects pain, activity, and expectations after hip arthroscopy.

31 August 2026 in Asian Spine Journal
Verified
Journal Article
Open access
PDF file
SPSapan Patel
Sapan Patel
HPHershil Patel
Hershil Patel
RSRohan Iyer Suresh
Rohan Iyer Suresh
BABibhas Amatya
Bibhas Amatya
SVSourabh Vellala
Sourabh Vellala
Julio J. J. JaureguiJulio J. J. Jauregui
Julio J. J. Jauregui
Study Design: Retrospective cohort study.Purpose: To compare three cervical sarcopenia metrics and frailty as preoperative predictors of unfavorable postoperative outcomes following surgical fixation of odontoid fractures.Overview of Literature: Sarcopenia is increasingly recognized as an indicator of physiologic vulnerability in spine surgery and thoracolumbar trauma. However, its prognostic significance in odontoid fractures remains unclear, and no previous study has directly compared cervical sarcopenia measurement sites in this population.Methods: Adult patients who underwent surgical fixation of traumatic odontoid fractures at a single level I trauma center were retrospectively reviewed. Sarcopenia was quantified on perioperative computed tomography using sternocleidomastoid, prevertebral, and paraspinal cross-sectional area normalized to the C3 vertebral body area. Frailty was assessed using the 5-factor modified frailty index (mFI-5), with hypertension status confirmed through a review of prescribed medications. Associations with postoperative outcomes were evaluated using threshold-based analyses, intercorrelation testing, subgroup analysis of combined low-sarcopenia/high-frailty patients, and an exploratory Combined Sarcopenia-Frailty Score.Results: This study included 61 patients (mean age, 61.7 years; 50.8% female). The three sarcopenia metrics were only modestly intercorrelated (Spearman rho, 0.34–0.47), with 46.7%–53.3% overlap among patients in the most sarcopenic quartiles. No individual sarcopenia or mFI-5 threshold independently predicted postoperative outcomes. However, patients in the most sarcopenic quartile on any cervical metric with an mFI-5 ≥2 (n=11) experienced higher rates of mortality, urinary tract infection, pneumonia, and nonunion. In exploratory receiver operating characteristic analysis, the Combined Sarcopenia-Frailty Score exhibited moderate discrimination for significant adverse events, with an area under the curve of 0.73 and an optimal threshold of ≥9.Conclusions: Cervical sarcopenia and frailty were not independently associated with adverse outcomes following odontoid fracture fixation. However, their combination identified patients at substantially higher risk for mortality, complications, and nonunion, supporting a potential role for combined preoperative risk stratification (Level of Evidence: level III).